This is the authors' abstract. We don't add key points for this paper.
Prostaglandin D2 (PGD2) acting at the CRTH2 receptor (chemoattractant receptor-homologous molecule expressed on Th2 cells) has been linked with a variety of allergic and other inflammatory diseases. We describe a family of indole-1-sulfonyl-3-acetic acids that are potent and selective CRTH2 antagonists that possess good oral bioavailability. The compounds may serve as novel starting points for the development of treatments of inflammatory disease such as asthma, allergic rhinitis, and atopic dermatitis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Armer et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: